Pelvic lymph-node staging with (18)F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

PURPOSE: The detection of lymph-node metastases (N1) with conventional imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) is inadequate for primarily diagnosed prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) PET/CT is successfully introduced for the stagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, B. H. E., Bodar, Y. J. L., Zwezerijnen, G. J. C., Meijer, D., van der Voorn, J. P., Nieuwenhuijzen, J. A., Wondergem, M., Roeleveld, T. A., Boellaard, R., Hoekstra, O. S., van Moorselaar, R. J. A., Oprea-Lager, D. E., Vis, A. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835187/
https://www.ncbi.nlm.nih.gov/pubmed/32789599
http://dx.doi.org/10.1007/s00259-020-04974-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835187/
https://www.ncbi.nlm.nih.gov/pubmed/32789599
http://dx.doi.org/10.1007/s00259-020-04974-w

Ejemplares similares